Eucerin Launches Its First Medical Product with Sun Protection Factor 100

• Eucerin expanding its sun protection portfolio with the introduction of the brand’s first medical device
• ACTINIC CONTROL SPF100 helps prevent actinic keratosis and non-melanoma skin cancer
• The launch campaign demonstrates the influence of dermatological innovations on the lives of people with skin problems
  

Hamburg, February 24, 2021 – Actinic keratosis is the world’s most common precursor to non-melanoma skin cancer and can often be attributed to the influence of the sun’s rays. An especially high sun protection factor combats sun-induced skin damage and provides people whose skin is already impaired with the necessary protection. Eucerin is therefore now expanding its portfolio to include another product innovation: Eucerin ACTINIC CONTROL SPF100. This is the first medical device to be launched by the dermocosmetics brand. The reliable sun protection provided thus also emphasizes Eucerin’s medical expertise.

With its new innovation Eucerin ACTINIC CONTROL SPF100, Beiersdorf’s dermocosmetics brand, is now offering new and effective sun protection which prevents actinic keratosis and non-melanoma skin cancer while also providing skin which is sensitive to the sun with effective protection from sun-induced skin damage. As such, it also serves as adjuvant treatment for patients already affected by actinic keratosis. “The highly effective combination of high UVA/UVB protection and broad-spectrum filters offers our consumers maximum sun protection. As intensive protection is important in particular for skin, which is already damaged, we also tested its skin tolerance on patients with skin which is sensitive to the sun and with actinic keratosis,” explains Dr. Gitta Neufang, Chief Innovation and Medical Officer. 

In addition to high sun protection and very good skin tolerance, the product stands out thanks to its texture – Eucerin ACTINIC CONTROL SPF100 is a fluid with a non-greasy, readily absorbed, and light texture, making it more pleasant for those affected to use. This new product underscores the parent company Beiersdorf’s pronounced skincare expertise that also takes into account the special needs of consumers with dermatological indications.

The product launch is accompanied by a global campaign in which Tony from the UK shares his experience of being diagnosed with actinic keratosis. “I wanted to protect myself from skin cancer while definitely spending more time with my son and doing the things I love, like playing football and golf, cycling, and going to the beach,” he says in an interview with Eucerin. This is now possible thanks to the reliable sun protection factor, as he no longer has to worry about whether he has adequate protection when he spends time outdoors with his son. His story is another example that supports the Eucerin brand purpose: “WE BELIEVE IN THE LIFE-CHANGING POWER OF DERMATOLOGICAL SKINCARE.”